WHO gave blessing for Coronavirus vaccine emergency use programme : China


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ WHO gave blessing for Coronavirus vaccine emergency use programme : China
China launched its emergency program in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official.

The World Health Organization supported China's campaign to vaccinate certain people against coronavirus in July while clinical trials were still underway, a Chinese health official said on Friday, although some experts have expressed concern about the move.

China launched its emergency program in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official.

Hundreds of thousands of essential workers and other limited groups of people considered at high risk of infection have been given the vaccine, even though its efficacy and safety had not been fully established as Phase 3 clinical trials were incomplete, raising concerns among experts.

"At end-June, China's State Council approved a plan of COVID-19 vaccine emergency use program," Zheng told a news conference.

"After the approval, on June 29, we made a communication with the relevant representatives of the WHO Office in China, and obtained support and understanding from WHO," Zheng said.

Countries have the autonomy to issue emergency use authorization for any health product according to the national regulations and legislations, Dr. Mariangela Simão, assistant director-general at the WHO, said on Friday at a news conference in Geneva.

WHO chief scientist Soumya Swaminathan said earlier this month that emergency use authorization for coronavirus vaccine is a "temporary solution," and that the long-term solution lay in the completion of Phase 3 trials.

Beijing has not publicly released full details of its emergency use program.

At least three vaccine candidates, including two developed by state-backed China National Biotec Group (CNBG) and one from Sinovac Biotech, all in Phase 3 trials overseas, are included in the emergency use program.

A fourth experimental vaccine developed by CanSino Biologics was approved to be used in the Chinese military in June.

China's annual production capacity of COVID-19 vaccines is expected to reach 610 million doses by end-2020 and 1 billion doses by 2021, Zheng said.

In China, the vaccine price will be affordable for the general public, Zheng added

Tags : #WHO #COVID-19 #Vaccine #Emergency #China

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026